Patents by Inventor Didier Rotticci

Didier Rotticci has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • New Compounds II
    Publication number: 20080188503
    Abstract: The present invention relates to a compound of formula (I): as a free base or a pharmaceutically acceptable salt thereof. The present invention also relates to pharmaceutical formulations containing said compound and to the use of said compound in therapy. The present invention further relates to a process for the preparation of the compound of formula (I).
    Type: Application
    Filed: June 27, 2007
    Publication date: August 7, 2008
    Applicant: AstraZenaca AB
    Inventors: Jeremy Burrows, Fernando Huerta, Tobias Rein, Didier Rotticci, Karin Staaf, Dominika Turek
  • New Compounds I
    Publication number: 20080188502
    Abstract: The present invention relates to a compound of formula (I): as a free base or a pharmaceutically acceptable salt thereof. The present invention also relates to pharmaceutical formulations containing said compound and to the use of said compound in therapy. The present invention further relates to a process for the preparation of compound of formula (I) and to new intermediates used therein.
    Type: Application
    Filed: June 27, 2007
    Publication date: August 7, 2008
    Applicant: AstraZeneca AB
    Inventors: Jeremy Burrows, Fernando Huerta, Fredrik Lake, Torben Pedersen, Didier Rotticci, Tobias Rein, Karin Staaf, Ulrika Yngve
  • New Compounds 318
    Publication number: 20080058349
    Abstract: This invention relates to novel compounds having the structural formula I below: and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.
    Type: Application
    Filed: June 11, 2007
    Publication date: March 6, 2008
    Applicants: Astrazeneca AB, Astex Therapeutics Ltd
    Inventors: Stefan Berg, Jorg Holenz, Katharina Hogdin, Jacob Kihlstrom, Karin Kolmodin, Johan Lindstrom, Niklas Plobeck, Didier Rotticci, Fernando Sehgelmeble, Maria Wirstam
  • New Compounds 319
    Publication number: 20070299087
    Abstract: This invention relates to novel compounds having the structural formula I below: and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.
    Type: Application
    Filed: June 11, 2007
    Publication date: December 27, 2007
    Applicants: AstraZeneca AB, Astex Therapeutics Ltd.
    Inventors: Stefan Berg, Jorg Holenz, Katharina Hogdin, Karin Kolmodin, Niklas Plobeck, Didier Rotticci, Fernando Sehgelmeble
  • New benzimidazole derivatives
    Publication number: 20060287377
    Abstract: Compounds of formula I, wherein R1, m, R2, R3, p, n, R5 and R9 are as defined as in the specification, salts, solvates or solvated salts thereof, processes for their preparation, intermediates used in the preparation thereof, pharmaceutical formulations containing said compounds and the use of said compounds in therapy.
    Type: Application
    Filed: May 13, 2004
    Publication date: December 21, 2006
    Inventors: Yevgeni Besidski, Inger Kers, Martin Nylof, Didier Rotticci, Andis Slaitas, Mats Svensson
  • Heterocyclic amides exhibiting and inhibitory activity at the vanilloid receptor 1(vr1)
    Publication number: 20060223868
    Abstract: Compounds of formula I, wherein R1, n, R3, R4, R7, R8 and P are as defined in the specification, salts, solvates or solvated salts thereof, processes for their preparation, new intermediates used in the preparation thereof, pharmaceutical compositions containing said compounds and the use of said compounds in therapy.
    Type: Application
    Filed: April 26, 2004
    Publication date: October 5, 2006
    Applicant: AstraZeneca AB
    Inventors: Yevgeni Besidski, William Brown, Shawn Johnstone, Denis Labrecque, Alexander Munro, Didier Rotticci, Christopher Walpole, Ronald Zemribo, Andreas Petersson